A recent study reports that a new #immunotherapy using autologous #TCellTherapy targeting multiple #TumorAntigens has shown promising safety and clinical effects in a first-in-human phase 1/2 #ClinicalTrial for #PancreaticCancer.
#PancreaticCancerTreatment
#PancreaticCancerTreatment
Autologous T cell therapy targeting multiple antigens shows promise treating pancreatic cancer – BioNews Central
A recent study reports that a new immunotherapy using autologous T cell therapy targeting multiple tumor antigens has shown promising safety and clinical effects in a first-in-human phase 1/2 trial for pancreatic cancer. ...
sbee.link
January 14, 2026 at 12:41 AM
A recent study reports that a new #immunotherapy using autologous #TCellTherapy targeting multiple #TumorAntigens has shown promising safety and clinical effects in a first-in-human phase 1/2 #ClinicalTrial for #PancreaticCancer.
#PancreaticCancerTreatment
#PancreaticCancerTreatment
Turning All Cancers Into Curable Diseases - Dr. Karen Knudsen MBA PhD - CEO, Parker Institute for Cancer Immunotherapy, joins me on Progress, Potential, And Possibilities #ProstateCancer #CARTCellTherapy #CheckpointInhibitors #TumorAntigens #TumorMicroenvironment www.youtube.com/watch?v=cyrO...
Dr. Karen Knudsen - CEO, Parker Institute for Cancer Immunotherapy - Turning All Cancers Curable
YouTube video by Progress, Potential, and Possibilities
www.youtube.com
September 19, 2025 at 8:49 PM
Turning All Cancers Into Curable Diseases - Dr. Karen Knudsen MBA PhD - CEO, Parker Institute for Cancer Immunotherapy, joins me on Progress, Potential, And Possibilities #ProstateCancer #CARTCellTherapy #CheckpointInhibitors #TumorAntigens #TumorMicroenvironment www.youtube.com/watch?v=cyrO...
A newly discovered class of peptides expressed in #PancreaticCancer cells could provide promising targets for #TCellTherapies and other approaches to combat #PancreaticTumors.
#TherapeuticTargets #TumorAntigens #Neoantigens #Immunotherapy
#TherapeuticTargets #TumorAntigens #Neoantigens #Immunotherapy
New targets for the treatment of pancreatic cancer – BioNews Central
A newly discovered class of peptides expressed in pancreatic cancer cells could provide promising targets for T-cell therapies and other approaches to combat pancreatic tumors. ...
sbee.link
May 8, 2025 at 11:30 PM
A newly discovered class of peptides expressed in #PancreaticCancer cells could provide promising targets for #TCellTherapies and other approaches to combat #PancreaticTumors.
#TherapeuticTargets #TumorAntigens #Neoantigens #Immunotherapy
#TherapeuticTargets #TumorAntigens #Neoantigens #Immunotherapy